Pharsight

Drugs that contain Metoclopramide Hydrochloride

1. Gimoti patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6770262 EVOKE PHARMA INC Nasal administration of agents for the treatment of gastroparesis
Mar, 2021

(3 years ago)

US11020361 EVOKE PHARMA INC Nasal formulations of metoclopramide
Dec, 2029

(5 years from now)

US11628150 EVOKE PHARMA INC Nasal formulations of metoclopramide
Dec, 2029

(5 years from now)

US11813231 EVOKE PHARMA INC Nasal formulations of metoclopramide
Dec, 2029

(5 years from now)

US8334281 EVOKE PHARMA INC Nasal formulations of metoclopramide
May, 2030

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jun 19, 2023

Market Authorisation Date: 19 June, 2020

Treatment: Nasal administration of metoclopramide for treatment of diabetic gastroparesis

Dosage: SPRAY, METERED;NASAL

How can I launch a generic of GIMOTI before it's drug patent expiration?
More Information on Dosage

GIMOTI family patents

Family Patents

2. Metozolv Odt patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6413549 SALIX PHARMS Fast-Dispersing solid oral dosage form containing coarse particles
Jul, 2017

(6 years ago)

Market Authorisation Date: 04 September, 2009

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

How can I launch a generic of METOZOLV ODT before it's drug patent expiration?
More Information on Dosage

METOZOLV ODT family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Reglan Odt patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6024981 MEDA PHARMS Rapidly dissolving robust dosage form
Apr, 2018

(6 years ago)

US6221392 MEDA PHARMS Rapidly dissolving robust dosage form
Apr, 2018

(6 years ago)

Market Authorisation Date: 10 June, 2005

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage

REGLAN ODT family patents

Family Patents